How big is the Biomarker Market | Valuation & Future Outlook 2025

Q: How big is the Biomarker market?

The market was exhibited at USD 69.5 billion in 2024 and is projected to reach USD 147.3 billion by 2031.

Q: What trends are influencing the biomarker market?

Trends include the rise of multi-omics approaches, digital biomarkers, liquid biopsy diagnostics, and AI-driven clinical tools.

Q: Which regions are leading in biomarker research and usage?

North America leads in R&D and adoption while Asia-Pacific is growing rapidly in trials and translational research.

Q: What drives the growth of biomarker market?

Demand for precision medicine, rise in chronic diseases, growth in pharma R&D, and regulatory support for companion diagnostics are main drivers.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA4805

Publication Date: Jul 2025

What is the size of the Biomarker Market?

According to 6Wresearch internal database and industry insights, the Biomarker Market was exhibited at USD 69.5 billion in 2024 and is projected to reach USD 147.3 billion by 2031, growing at a robust CAGR of 11.5% during the forecast period 2025–2031.

Due to rising demand for precision medicine, early disease detection, and the surge in chronic disease diagnostics and pharmaceutical R&D, the market is predicted to expand rapidly.

Key Growth Factors of the Biomarker Market

Increasing adoption of personalized and precision medicine
Growing prevalence of cancer, cardiovascular, and neurological disorders
Advancements in omics technologies and data analytics
Rising demand for non-invasive diagnostic and prognostic tools
Expanding pharmaceutical clinical trial activity using companion diagnostics

Biomarker Market Trends

There are numbers of trends which are shown in the biomarker market include the rise in multi-omics biomarkers combining genomics, proteomics, and metabolomics for comprehensive profiling. The preference for liquid biopsies and blood-based biomarkers is increasing due to their non-invasive nature and real-time monitoring capabilities. Companion diagnostics are increasingly being co-developed with targeted therapies, especially in oncology. AI-driven biomarker discovery and validation platforms are streamlining clinical trial design and speeding up time-to-market for novel therapies. The shift towards digital biomarkers using wearable devices and mobile apps is also gaining traction in neurology and metabolic disease monitoring.

Emerging Developments in the Biomarker Market

Biomarker market is seeing few emerging developments such as the next-generation sequencing (NGS)-based biomarker panels, single-cell biomarker analysis, and real-time monitoring platforms for chronic conditions. The research is rising into epigenetic and microbiome biomarkers for autoimmune and metabolic disorders. Biotech startups are collaborating with big pharma and health tech firms to deliver AI-based diagnostics and predictive biomarker models. Regulatory bodies like the FDA and EMA are accelerating biomarker qualification pathways, fostering clinical translation.